Publications by authors named "Douglas G McNeel"

100Publications

Infectious Tolerance as Seen With 2020 Vision: The Role of IL-35 and Extracellular Vesicles.

Front Immunol 2020 26;11:1867. Epub 2020 Aug 26.

Department of Surgery-Transplant Division, School of Medicine and Public Health, University of Wisconsin, Madison, WI, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2020.01867DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480133PMC
August 2020

Androgen deprivation as a tumour-immunomodulating treatment.

Nat Rev Urol 2020 Jul;17(7):371-372

Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-020-0328-6DOI Listing
July 2020

Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T.

J Natl Cancer Inst 2020 06;112(6):562-573

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djaa021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301097PMC
June 2020

Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy.

Cancer Immunol Immunother 2019 Oct 12;68(10):1661-1669. Epub 2019 Oct 12.

7007 Wisconsin Institutes for Medical Research, University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI, 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02394-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111534PMC
October 2019

Noninvasive Imaging and Quantification of Radiotherapy-Induced PD-L1 Upregulation with Zr-Df-Atezolizumab.

Bioconjug Chem 2019 05 19;30(5):1434-1441. Epub 2019 Apr 19.

Medical Physics Department , University of Wisconsin-Madison , 1111 Highland Avenue , Madison , Wisconsin 53705 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.bioconjchem.9b00178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521689PMC
May 2019

Antibody and fragment-based PET imaging of CTLA-4+ T-cells in humanized mouse models.

Am J Cancer Res 2019 1;9(1):53-63. Epub 2019 Jan 1.

Department of Medical Physics, University of Wisconsin-Madison Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356917PMC
January 2019

FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab.

J Immunother Cancer 2019 01 30;7(1):23. Epub 2019 Jan 30.

University of Wisconsin Carbone Cancer Center, 1111 Highland Ave, Madison, WI, 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0516-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354338PMC
January 2019

TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8 T Cells.

Cancer Immunol Res 2018 11 10;6(11):1364-1374. Epub 2018 Sep 10.

University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-18-0243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215515PMC
November 2018

Therapeutic Cancer Vaccines: How Much Closer Are We?

Authors:
Douglas G McNeel

BioDrugs 2018 Feb;32(1):1-7

7007 Wisconsin Institutes for Medical Research, University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI, 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40259-017-0257-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815920PMC
February 2018

Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer.

Eur J Nucl Med Mol Imaging 2018 Jan 19;45(1):110-120. Epub 2017 Aug 19.

Department of Medical Physics, University of Wisconsin - Madison, Madison, WI, 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3803-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700850PMC
January 2018

Androgen deprivation and immunotherapy for the treatment of prostate cancer.

Endocr Relat Cancer 2017 12 16;24(12):T297-T310. Epub 2017 Aug 16.

University of Wisconsin Carbone Cancer CenterMadison, Wisconsin, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-17-0145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669826PMC
December 2017

Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination.

J Immunother Cancer 2017 07 18;5(1):56. Epub 2017 Jul 18.

University of Wisconsin Carbone Cancer Center, 7007 Wisconsin Institutes for Medical Research, University of Wisconsin, Madison, 1111 Highland Avenue, Madison, WI, 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0260-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514519PMC
July 2017

Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8 T Cells.

Cancer Immunol Res 2017 08 20;5(8):630-641. Epub 2017 Jun 20.

University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-16-0374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821110PMC
August 2017

ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer.

Mol Pharm 2017 05 12;14(5):1782-1789. Epub 2017 Apr 12.

Department of Medical Physics, University of Wisconsin-Madison , Madison, Wisconsin 53705, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.molpharmaceut.7b00056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495656PMC
May 2017

DNA vaccines for prostate cancer.

Pharmacol Ther 2017 Jun 7;174:27-42. Epub 2017 Feb 7.

Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53705, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2017.02.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429198PMC
June 2017

TCR diversity - a universal cancer immunotherapy biomarker?

Authors:
Douglas G McNeel

J Immunother Cancer 2016 15;4:69. Epub 2016 Nov 15.

University of Wisconsin Carbone Cancer Center, 7007 Wisconsin Institutes for Medical Research, 1111 Highland Avenue, Madison, WI 53705 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0175-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109785PMC
February 2018

Mini-intronic plasmid vaccination elicits tolerant LAG3 CD8 T cells and inferior antitumor responses.

Oncoimmunology 2016 2;5(10):e1223002. Epub 2016 Sep 2.

Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1223002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087309PMC
September 2016

B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines.

Oncotarget 2016 Oct;7(42):67901-67918

Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356528PMC
October 2016

Immunotherapy for prostate cancer: False promises or true hope?

Cancer 2016 Dec 20;122(23):3598-3607. Epub 2016 Sep 20.

Medical Oncology Clinic, UW Carbone Cancer Center, University of Wisconsin at Madison, Madison, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115970PMC
December 2016

Antitumor vaccination of prostate cancer patients elicits PD-1/PD-L1 regulated antigen-specific immune responses.

Oncoimmunology 2016 Jun 28;5(6):e1165377. Epub 2016 Mar 28.

Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1165377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938302PMC
June 2016

Molecular Imaging of Immunotherapy Targets in Cancer.

J Nucl Med 2016 Oct 28;57(10):1487-1492. Epub 2016 Jul 28.

Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin University of Wisconsin Carbone Cancer Center, Madison, Wisconsin; and Department of Radiology, University of Wisconsin-Madison, Madison, Wisconsin

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050107PMC
http://dx.doi.org/10.2967/jnumed.116.177493DOI Listing
October 2016

SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer.

Oncotarget 2016 Aug;7(32):50997-51011

Department of Medicine, University of Wisconsin, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9802DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239454PMC
August 2016

PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization.

Cancer Immunol Res 2015 Aug 3;3(8):946-55. Epub 2015 Jun 3.

Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin. The Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0206DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527948PMC
August 2015

DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses.

Vaccine 2014 Mar 31;32(15):1707-15. Epub 2014 Jan 31.

Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2014.01.048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153342PMC
March 2014

Preclinical and clinical development of DNA vaccines for prostate cancer.

Urol Oncol 2016 Apr 12;34(4):193-204. Epub 2013 Dec 12.

Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439130038
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2013.09.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053490PMC
April 2016

Monitoring regulatory immune responses in tumor immunotherapy clinical trials.

Front Oncol 2013 6;3:109. Epub 2013 May 6.

Department of Medicine, University of Wisconsin Carbone Cancer Center Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644716PMC
May 2013

Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination.

J Immunother Cancer 2013 29;1. Epub 2013 May 29.

Department of Medicine, University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2051-1426-1-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986973PMC
April 2014

Current controversies in the management of biochemical failure in prostate cancer.

Clin Adv Hematol Oncol 2012 Nov;10(11):716-22

Division of Hematology/Oncology, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin 53705-2275, USA.

View Article

Download full-text PDF

Source
November 2012

Immunization with a prostate cancer xenoantigen elicits a xenoantigen epitope-specific T-cell response.

Oncoimmunology 2012 Dec;1(9):1546-1556

Department of Medicine; University of Wisconsin; Madison, WI USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.22564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525610PMC
December 2012

Vaccination using peptides spanning the SYT-SSX tumor-specific translocation.

Expert Rev Vaccines 2012 Dec;11(12):1401-4

University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erv.12.122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556272PMC
December 2012

Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence.

Expert Rev Vaccines 2012 Nov;11(11):1315-7

University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/erv.12.107
Publisher Site
http://dx.doi.org/10.1586/erv.12.107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557828PMC
November 2012

DNA Vaccines for Prostate Cancer.

Curr Cancer Ther Rev 2012 Nov;8(4):254-263

Department of Medicine, University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://openurl.ingenta.com/content/xref?genre=article&is
Publisher Site
http://dx.doi.org/10.2174/157339412804143113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935480PMC
November 2012

The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer.

Cancer Immunol Immunother 2013 Mar 30;62(3):585-96. Epub 2012 Oct 30.

University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-012-1363-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577997PMC
March 2013

Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.

Prostate 2012 May 30;72(7):730-40. Epub 2011 Aug 30.

Department of Medicine, University of Wisconsin, Madison, Wisconsin 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.21477DOI Listing
May 2012

T cells localized to the androgen-deprived prostate are TH1 and TH17 biased.

Prostate 2012 Aug 27;72(11):1239-47. Epub 2011 Dec 27.

Department of Cancer Biology, University of Wisconsin, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673717PMC
August 2012

Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.

J Immunother 2011 Oct;34(8):569-80

Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e31822b5b1dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175298PMC
October 2011

Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer.

Cancer Res 2011 Nov 31;71(21):6785-95. Epub 2011 Aug 31.

Department of Medicine and Oncology, University of Wisconsin-Madison, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-2127DOI Listing
November 2011

CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells.

Cancer Immunol Immunother 2011 Jun 25;60(6):781-92. Epub 2011 Feb 25.

Department of Medicine, University of Wisconsin, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-011-0987-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319721PMC
June 2011

IgG responses to tissue-associated antigens as biomarkers of immunological treatment efficacy.

J Biomed Biotechnol 2011 19;2011:454861. Epub 2010 Dec 19.

Carbone Comprehensive Cancer Center, University of Wisconsin, 1111 Highland Avenue, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/454861DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010827PMC
April 2011

Sipuleucel-T: immunotherapy for advanced prostate cancer.

Open Access J Urol 2011 May 3;3:49-60. Epub 2011 May 3.

University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OAJU.S13069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818937PMC
May 2011

The SSX family of cancer-testis antigens as target proteins for tumor therapy.

Clin Dev Immunol 2010 11;2010:150591. Epub 2010 Oct 11.

Departments of Medicine and Oncology, University of Wisconsin-Madison, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2010/150591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963798PMC
February 2011

Identification of autoantibodies in a patient with testicular cancer and concurrent inflammatory bowel disease.

J Clin Oncol 2010 Nov 30;28(33):e680-3. Epub 2010 Aug 30.

University of Wisconsin, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.30.2893DOI Listing
November 2010

Antibody responses to prostate-associated antigens in patients with prostatitis and prostate cancer.

Prostate 2011 Feb;71(2):134-46

University of Wisconsin Carbone Comprehensive Cancer Center, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.21229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978272PMC
February 2011

DNA vaccines for the treatment of prostate cancer.

Expert Rev Vaccines 2010 Jul;9(7):731-45

Department of Medicine, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erv.10.64DOI Listing
July 2010

Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses.

Hum Immunol 2010 May 5;71(5):496-504. Epub 2010 Mar 5.

Department of Cancer Biology, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2010.02.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856724PMC
May 2010

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.

Cancer Immunol Immunother 2010 Jun 6;59(6):943-53. Epub 2010 Feb 6.

Department of Medicine, University of Wisconsin, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-010-0820-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038205PMC
June 2010

Prioritization of cancer antigens: keeping the target in sight.

Expert Rev Vaccines 2009 Dec;8(12):1657-61

Department of Medicine, University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, WI 53701, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erv.09.134DOI Listing
December 2009

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.

J Clin Oncol 2009 Sep 27;27(25):4047-54. Epub 2009 Jul 27.

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Department of Biostatistics, University of Wisconsin, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.9968DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734418PMC
September 2009

An aberrant prostate antigen-specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans.

J Clin Invest 2009 Jul;119(7):2031-41

Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI38332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701875PMC
July 2009

Methods for constructing and evaluating antitumor DNA vaccines.

Methods Mol Biol 2009 ;542:211-43

Department of Medicine, Section of Medical Oncology, University of Wisconsin-Madison, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-59745-561-9_12DOI Listing
July 2009

Endothelin receptor antagonists in cancer therapy.

Cancer Invest 2007 Dec;25(8):785-94

Genitourinary Oncology Research Group, University of Wisconsin, Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900701522588DOI Listing
December 2007

GVAX: an allogeneic, whole-cell, GM-CSF-secreting cellular immunotherapy for the treatment of prostate cancer.

Expert Opin Biol Ther 2007 Dec;7(12):1893-902

Internal Medicine Resident University of Wisconsin, Department of Medicine, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.7.12.1893DOI Listing
December 2007

Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor.

Prostate 2007 Dec;67(16):1781-90

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20665DOI Listing
December 2007

MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis.

J Immunother 2007 Oct;30(7):675-83

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e3180de4d19DOI Listing
October 2007

Antibody and T-cell responses specific for the androgen receptor in patients with prostate cancer.

Prostate 2007 Dec;67(16):1729-39

Department of Oncology, University of Wisconsin-Madison, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pros.20652
Publisher Site
http://dx.doi.org/10.1002/pros.20652DOI Listing
December 2007

Immunotherapy for prostate cancer - recent progress in clinical trials.

Clin Adv Hematol Oncol 2007 Jun;5(6):465-74, 477-9

University of Wisconson School of Medicine and Public Health, Madison, WI, USA.

View Article

Download full-text PDF

Source
June 2007

Prostate cancer immunotherapy.

Authors:
Douglas G McNeel

Curr Opin Urol 2007 May;17(3):175-81

Department of Medicine, University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0b013e3280eb10ebDOI Listing
May 2007

Cellular immunotherapies for prostate cancer.

Authors:
Douglas G McNeel

Biomed Pharmacother 2007 Jul 26;61(6):315-22. Epub 2007 Jan 26.

Department of Medicine/Medical Oncology, University of Wisconsin Comprehensive Cancer Center, K4/518 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2006.12.006DOI Listing
July 2007

Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells.

Cancer Immunol Immunother 2007 Jun 11;56(6):885-95. Epub 2006 Nov 11.

Department of Medicine, University of Wisconsin, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-006-0241-8DOI Listing
June 2007

Effects of a monoclonal anti-alphavbeta3 integrin antibody on blood vessels - a pharmacodynamic study.

Invest New Drugs 2007 Feb 26;25(1):49-55. Epub 2006 Sep 26.

Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-006-9013-8DOI Listing
February 2007

Identification of autoantibodies elicited in a patient with prostate cancer presenting as dermatomyositis.

Int J Urol 2006 Mar;13(3):211-7

Department of Medicine, University of Wisconsin, Madison, Wisconsin 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1442-2042.2006.01263.xDOI Listing
March 2006

A phase I study of a DNA vaccine targeting prostatic Acid phosphatase in patients with stage D0 prostate cancer.

Clin Genitourin Cancer 2005 Dec;4(3):215-8

Genitourinary Oncology Group at University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CGC.2005.n.036DOI Listing
December 2005

Humoral immune responses to testis antigens in sera from patients with prostate cancer.

Cancer Immun 2006 Jan 10;6. Epub 2006 Jan 10.

Department of Medicine, University of Wisconsin, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
January 2006

Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).

Vaccine 2006 Jan 9;24(3):293-303. Epub 2005 Aug 9.

Department of Medicine, Section of Medical Oncology, University of Wisconsin-Madison, K4/518 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2005.07.074DOI Listing
January 2006

Prostate cancer antigens and vaccines, preclinical developments.

Authors:
Douglas G McNeel

Cancer Chemother Biol Response Modif 2005 ;22:247-61

Department of Medicine, University of Wisconsin, K4/518 Clinical Science Center, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0921-4410(04)22011-7DOI Listing
October 2005

Antigen-specific IgG elicited in subjects with prostate cancer treated with flt3 ligand.

J Immunother 2005 May-Jun;28(3):268-75

Department of Medicine, Section of Medical Oncology, University of Wisconsin, Madison, Wisconsin 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.cji.0000158853.15664.0cDOI Listing
October 2005

Newer therapies in advanced prostate cancer.

Clin Prostate Cancer 2004 Dec;3(3):150-6

Department of Medicine, University of Wisconsin Comprehensive Cancer Center, Clinical Science Center, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/cgc.2004.n.025DOI Listing
December 2004

Immune-based therapies for prostate cancer.

Immunol Lett 2005 Jan;96(1):3-9

Department of Medicine, University of Wisconsin Medical School, 600 Highland Avenue, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2004.06.009DOI Listing
January 2005

Identification of antigen-specific IgG in sera from patients with chronic prostatitis.

J Clin Immunol 2004 Sep;24(5):492-502

Department of Medicine, Section of Medical Oncology, University of Wisconsin, Madison, Wisconsin 53792, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1023/B:JOCI.00000409
Web Search
http://link.springer.com/10.1023/B:JOCI.0000040920.96065.5a
Publisher Site
http://dx.doi.org/10.1023/B:JOCI.0000040920.96065.5aDOI Listing
September 2004

Soluble cytokines can act as effective adjuvants in plasmid DNA vaccines targeting self tumor antigens.

Immunobiology 2003 ;207(3):179-86

Division of Oncology, University of Washington, Seattle, Washington 98195-6527, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1078/0171-2985-00230DOI Listing
January 2004